U025 Cases in Genetic Skin Diseases: Clinicopathological Clues
DESCRIPTION
This session will highlight clinicopathologic clues that support the diagnosis of genetic skin diseases and show how integrating clinical findings, dermatopathology, and genetic testing can lead to earlier diagnosis and more precise management. Expert clinicians and investigators will discuss practical diagnostic patterns, genotype phenotype correlations, and real world approaches to multidisciplinary care. Cases will emphasize how to recognize key findings, avoid diagnostic delay, and use pathology and genetics to guide counseling, surveillance, and treatment. This session is designed for dermatologists, dermatopathologists, pediatric dermatologists, trainees, and others interested in genodermatoses and complex diagnostic care.
LEARNING OBJECTIVES
Diagnose clinical signs of genetic skin diseases more effectively
Recognize the dermatopathological clues pointing to genetic skin diseases
Effectively utilize and integrate clinicopathological correlation with genetic testing
SCHEDULE
7:30 AM
Discussion
DIRECTOR
Nessa Aghazadeh Monandesi, MD, FAAD
Mayo Clinic
SPEAKERS
Shruti Agrawal, MD, FAAD
Harper Price, MD, FAAD
DISCLOSURES
Nessa Aghazadeh Monandesi, MD, FAAD
Abeona Therapeutics – Advisory Board(Honoraria); AlphaSights – Consultant (1099 relationship)(Fees); Chiesi Farmaceutici – Advisory Board(Honoraria); Leo Pharma – Consultant (1099 relationship)(Honoraria); Mosaic Research Management – Consultant (1099 relationship)(Fees); The Dedham Group – Consultant (1099 relationship)(Fees);
Shruti Agrawal, MD, FAAD
No financial relationships exist with ineligible companies.
Harper Price, MD, FAAD
No financial relationships exist with ineligible companies.